Affimed Shares Are Trading Lower. The Company Reported Findings From a Post-hoc Exposure-response Analysis in Patients Treated With 480 Mg AFM24.
Affimed Shares Are Trading Lower. The Company Reported Findings From a Post-hoc Exposure-response Analysis in Patients Treated With 480 Mg AFM24.
Affimed的股票價格下跌。公司報告了在接受480毫克AFM24治療的患者中進行的事後暴露反應分析的發現。
Affimed Shares Are Trading Lower. The Company Reported Findings From a Post-hoc Exposure-response Analysis in Patients Treated With 480 Mg AFM24.
Affimed的股票價格下跌。公司報告了在接受480毫克AFM24治療的患者中進行的事後暴露反應分析的發現。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間